Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12
about
Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cellsDesmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desminSarcoglycan subcomplex expression in normal human smooth muscleFunctional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2AAbsence of gamma-sarcoglycan (35 DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contracturesMutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D)A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies.A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus.Sarcospan-deficient mice maintain normal muscle functionmyotilin Mutation found in second pedigree with LGMD1AFilamin 2 (FLN2): A muscle-specific sarcoglycan interacting proteinMild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutationThe seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical originsDisruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutationsMultiple PEX genes are required for proper subcellular distribution and stability of Pex5p, the PTS1 receptor: evidence that PTS1 protein import is mediated by a cycling receptorMolecular organization of sarcoglycan complex in mouse myotubes in cultureAnalysis of human sarcospan as a candidate gene for CFEOM1Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profilingGenetic Engineering of Dystroglycan in Animal Models of Muscular DystrophyExpression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complexPrivate beta- and gamma-sarcoglycan gene mutations: evidence of a founder effect in Northern ItalySarcoglycan isoforms in skeletal muscleLimb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethoninrAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophyDefective assembly of sarcoglycan complex in patients with beta-sarcoglycan gene mutations. Study of aneural and innervated cultured myotubesMutations in the caveolin-3 gene: When are they pathogenic?Localization of sarcoglycan, neuronal nitric oxide synthase, beta-dystroglycan, and dystrophin molecules in normal skeletal myofiber: triple immunogold labeling electron microscopyDystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophyMild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chainStructure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophyCharacterization of delta-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophyLimb-girdle muscular dystrophies: where next after six decades from the first proposal (Review).Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations.How the magnitude of clinical severity and recurrence risk affects reproductive decisions in adult males with different forms of progressive muscular dystrophy.Making sense of the limb-girdle muscular dystrophies.Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complexInvestigation of muscle disease.Limb-girdle Muscular Dystrophies in India: A Review.
P2860
Q22253448-631893F1-5970-444A-BC5E-8214DBB55AC8Q24291234-A1F0A20A-B107-4E46-89ED-E38E6A63038AQ24302925-0E22090F-8C01-4663-A275-4E9E9ACF9FB3Q24310208-5711A134-546D-4B31-9D91-2D6B68FD5A63Q24313751-AD890D69-B4D9-4CBC-974B-8CE9A4C6358CQ24318933-5DFB9DDD-5DDC-403E-B264-9F01820A8288Q24517929-7FB1E6E7-4D5F-4960-9D6E-53CD7D801A4AQ24517965-A0C4601A-0E65-40AF-BB58-CD43F866889EQ24539083-7E157EB5-5A12-4AA2-8531-FCC7C921C8CDQ24554300-F9A99E50-38BD-4E71-B8AC-E830EC2A78C6Q24616089-896E2427-14CB-4490-A9E0-86208D6905AEQ24632485-88C90BFA-424D-426F-BF00-7E1FB33A2186Q24675581-03FDE830-1080-43D4-A5D5-B0FDB32814B4Q24678868-2BFAE01F-E646-42DA-8292-8705CD39B71AQ24680877-F102DD3B-D297-4E10-9759-B7E4BA9B9782Q24681367-60600F32-9606-4C37-8ADE-1377DFBE8F91Q24681727-E563ACD8-A14B-44C7-B06B-FAD9E7821360Q24685886-676D6C95-4996-4ED7-BC66-1E46FE1DDF20Q24795817-6CF19D70-8EC7-43A9-BC9F-8B8BC3ECB54BQ24815340-7CC9A08A-B06C-4ACD-B702-E7EA0257EFA9Q26783980-3140AB4F-DD7A-42EE-BCBD-7F806CEEB7D4Q28138974-D0B334AB-FF68-459F-A43A-9E5FEB8F0EC8Q28139610-5479B89A-0625-4B0C-8A19-8F85E6251266Q28141128-C3FB500A-6FEB-43A4-A166-2A15025CF3D7Q28143777-FA8B2BB0-2166-4DAD-BD1F-3BF5A6671F41Q28144597-71D6B4F0-B502-4198-88DF-8B138ACCED58Q28203915-24F58129-8B34-4E49-9B55-89291CC55F85Q28205032-C9A81558-7DB7-49B6-97E3-71AA3A9C74F7Q28211587-ED6ABF0C-2AD8-4CF7-9742-0E13310D09F4Q28213646-C5F12E6A-BAAC-44C9-83F8-040167AB5390Q28238601-23C17570-9D67-45E8-B7A2-FCC0731736D4Q28296180-E51EF7A0-50DC-465A-A2C1-0A927C121C91Q28298383-1FE535AD-EC92-47CA-B0E6-FDB0C4651AE7Q33608787-B68DC857-E0F5-48D6-A605-6AA91DA31019Q33679819-8F938A4A-AAF1-455E-8FD6-D813A782F07AQ33680323-B665BE88-8146-4C71-A636-C589999F73CDQ33701932-4141A01E-A4B0-4A2E-9B18-35B595AE6738Q33732306-A9F38CCB-86CA-4040-990A-0CE943FD92EEQ33735060-3A1BEC5F-3634-4647-AD8B-A6C42E120D1BQ33795491-559A2FDA-BD66-46BA-B9CA-AC0E0171E1E9
P2860
Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@ast
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@en
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@en-gb
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@nl
type
label
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@ast
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@en
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@en-gb
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@nl
prefLabel
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@ast
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@en
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@en-gb
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@nl
P2093
P356
P1433
P1476
Beta-sarcoglycan: characteriza ...... cular dystrophy linked to 4q12
@en
P2093
C Slaughter
V Allamand
P2888
P304
P356
10.1038/NG1195-257
P407
P577
1995-11-01T00:00:00Z
P5875
P6179
1050223588